Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guided Therapeutics, Inc.

0.2740
0.0000
Volume:- -
Turnover:- -
Market Cap:22.91M
PE:-0.95
High:0.2740
Open:0.2740
Low:0.2740
Close:0.2740
52wk High:0.3220
52wk Low:0.0644
Shares:83.60M
Float Shares:27.93M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2881
EPS(LYR):-0.0372
ROE:43.94%
ROA:-129.56%
PB:-2.99
PE(LYR):-7.36

Loading ...

Nov 14, 2018

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2018

Major Issues Report

8-K - Current report
Sep 06, 2018

Major Issues Report

8-K - Current report
Aug 14, 2018

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2018

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2018

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 25, 2018

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 21, 2018

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2018

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 17, 2018

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 20, 2017

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2017

Major Issues Report

8-K/A [Amend] - Current report
Oct 25, 2017

Major Issues Report

8-K - Current report
Aug 24, 2017

Major Issues Report

8-K - Current report
Aug 18, 2017

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 17, 2017

Major Issues Report

8-K/A [Amend] - Current report
Aug 14, 2017

Major Issues Report

8-K - Current report
Jun 26, 2017

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 07, 2017

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 24, 2017

Major Issues Report

8-K - Current report